Revere Healthcare™ enables investors to search, discover, and act upon key clinical and regulatory events that can significantly drive the near-term performance and long-term value creation of biopharmaceutical and medical technology companies.

---

The Revere Healthcare™ datafeed provides ongoing coverage on two types of corporate events and three types of regulatory events: 

• Patent expiration and conference
  
• New Drug Application (NDA)/Biologic License Application (BLA) Filings, FDA Advisory Meetings, and Prescription Drug User Fee Act (PDUFA)
  

Relying on Revere’s proprietary drug database that tracks the pipeline of all US- and Canadian-listed biopharmaceutical and medical technology companies, the real-time Revere HealthcareT datafeed offers unmatched tracking capability.

Revere Healthcare™ includes the following key information:

• Tradename and generic name of each drug candidate
• Name and ticker of the drug/device developer(s)
• Indication(s) seeking FDA approval
• Drug/candidate primary mechanism of action (PMOA)
• Revere Hierarchy™ location of the relevant drugs/device
• Revere Tradenames™: Directly competing drugs/devices that are either approved or in late clinical stage of development
• Complete data on filings, meetings and dates for over three years.